| 【Company Research】Netease (NTES US) - Solid pipeline to fuel FY24 revenue growth |
| 【Company Research】iQIYI (IQ US) - Improving profitability with solid guidance |
| 【Company Research】JNBY Design (3306 HK) – An impressive beat but a conservative outlook |
| 【Company Research】Baidu (BIDU US) - Eyeing on the pace of gen-AI rev generation |
| 【Sector Research】Capital Goods - Strong sales of AWPs & forklifts in Jan; Tower cranes the worst |
| 【Fixed Income Research】Yanlord: Weaker results but progresses in refinancing |
| 【Company Research】Shengyi Tech (600183 CH) - FY23 preliminary results review; expect gradual recovery in 2024 |
| 【Company Research】ZTE (763 HK) - MWC 2024: Industry moves towards developing 6G |
| 【Company Research】BeiGene (BGNE US) – Expect a productive 2024 for early pipeline assets |
| 【公司研究】巨子生物 (2367 HK) - 线上销售数据跟踪：1月可复美增速延续强势 |
公司地址：香港中環花園道三號冠君大廈45-46樓
電話：（852） 3900-0888 傳真：（852） 3761-8788
招銀國際版權所有 Copyright © 2019-2026 CMB International Capital Corporation Limited. All rights reserved.
